A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy. Cureus. 2024 Oct 19;16(10):e71867. doi: 10.7759/cureus.71867. PMID: 39559603; PMCID: PMC11573227.

Tags: cancer immunotherapy, Cetuximab, General Internal Medicine, hematology-oncology, Hematology/Oncology, Hospitalist, immune-related adverse event, irae, pembrolizumab side effect, posterior reversible encephalopathy syndrome, pres, Publications

Interdisciplinary Weight Management in a Safety-Net Health System: A Pilot Implementation Study

DeCan C, Thure K, Pedley N, Cervantes B, Camargo O, Fing Castro K, Cabral J, Gallardo M, Rodriguez Reyes D, Perez A, Young S, Nafisi[...]

Mobile point-of-care testing to improve access to care for people experiencing homelessness and diabetes in Los Angeles

Berger-Cahn T, Shannon EM, Zunner-Keating B, Weaver C, Lee J, Takada S, Lilley CM, Metushi IG, Garner OB. Mobile point-of-care testing to improve access to[...]

Susan Ettner, PhD and Dennis J. Slamon, MD, PhD Elected to the National Academy of Medicine

The UCLA Department of Medicine (DoM) is pleased to congratulate Susan Ettner, PhD and Dennis Slamon, MD, PhD, on their election to the National Academy[...]